MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$19,525K
Net Income
-$5,252K
Net Profit Margin
-26.90%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
Product
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Total revenues
19,525
20,904
17,904*
18,461
Cost of goods sold
2,662
3,001
7,108*
2,248
Gross profit
16,863
17,903
10,796*
-
Research and development
11,104
11,359
6,021*
11,168
Selling, general, and administrative
11,313
13,087
8,378*
13,613
License royalties
50
-
63*
-
Total operating costs and expenses
22,467
24,446
14,461*
27,029
Loss from operations
-5,604
-6,543
-3,665*
-8,568
Interest and other income
2,372
1,352
-2,445*
1,916
Loss before income taxes
-3,232
-5,191
-6,110*
-6,652
Provision for income taxes
7
5
-815*
346
Net loss
-3,239
-5,196
-5,295*
-6,998
Foreign currency translation
-2,013
-863
3,141*
-1,083
Comprehensive loss
-5,252
-6,059
-2,154
-8,081
Basic EPS
-0.07
-0.12
-0.049
-0.16
Diluted EPS
-0.07
-0.12
-0.049
-0.16
Basic Average Shares
45,318,000
45,104,476
44,337,587
44,626,943
Diluted Average Shares
45,318,000
45,104,476
44,337,587
44,626,943
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Revenue From Contract
With Customer...
$19,025K
Revenue From Contract
With Customer...
$500K
Comprehensive loss
-$5,252K
(41.97%↑ Y/Y)
Product
$19,025K
License
$500K
Net loss
-$3,239K
(64.98%↑ Y/Y)
Foreign currency
translation
-$2,013K
(-1111.56%↓ Y/Y)
Revenue from contract
with customer,...
$19,525K
(-14.36%↓ Y/Y)
Loss before income
taxes
-$3,232K
(64.67%↑ Y/Y)
Provision for income taxes
$7K
(-93.00%↓ Y/Y)
Interest and other income
$2,372K
(270.63%↑ Y/Y)
Total revenues
$19,525K
(-14.36%↓ Y/Y)
Loss from operations
-$5,604K
(42.75%↑ Y/Y)
Gross profit
$16,863K
Cost of goods sold
$2,662K
(-11.68%↓ Y/Y)
Total operating costs
and expenses
$22,467K
(-31.06%↓ Y/Y)
Selling, general, and
administrative
$11,313K
(-34.35%↓ Y/Y)
Research and development
$11,104K
(-10.02%↓ Y/Y)
License royalties
$50K
Buy us a coffee
Y-mAbs Therapeutics, Inc. (YMAB)
Y-mAbs Therapeutics, Inc. (YMAB)